Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Speeda® Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level

NCT01827917 is registered in ClinicalTrials.gov with Beijing Center for Disease Control and Prevention as lead sponsor.

NCT NCT01827917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Speeda® Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level
Lead sponsor
Beijing Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
December 31, 2014
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rabies vaccine allergy